Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (827)
- Medicine suspension (472)
- Complementary medicine cancellation (203)
- Medical device suspension (86)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (51)
- Medical device cancellation - certain devices within an entry (22)
- Registered medicine cancellation (12)
- Voluntary revocation at the request of the manufacturer (9)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Medical device cancellation (1)
- Medical device cancellation – certain devices within an entry (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Results for
"[search-keyword]"
Search
1780 result(s) found, displaying 551 to 575
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 19/01/2022
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 19/01/2022
-
Cancellation or suspensionRegulatory action due to The sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a).The sponsor was notified of the cancellation under s.41GN(1)(b) on 7 December 2021. Prior to the cancellation taking effect on 14 January 2022, 20 working days after the notification of the cancellation (s.41GQ), the sponsor requested the cancellation of the ARTG inclusion under s.41GL(d)., effective 14/01/2022
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 07/01/2022
-
Cancellation or suspensionRegulatory action due to Failure to comply with conditions of inclusion, effective 07/01/2022
-
Cancellation or suspensionRegulatory action due to Failure to comply with a condition of inclusion, the safety or performance of the Device is unacceptable and Certification made under 41FD(d) is incorrect, effective 04/01/2022
-
Cancellation or suspensionRegulatory action due to Failure to comply with conditions of inclusion, effective 04/01/2022
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 04/01/2022
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 01/01/2022
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 21/12/2021
-
Cancellation or suspensionRegulatory action due to Certification made under 41FD(d) is incorrect, effective 20/12/2021
-
Cancellation or suspensionRegulatory action due to Removal of Excluded Goods, effective 20/12/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 20/12/2021
-
Cancellation or suspensionRegulatory action due to Removal of Excluded Goods, effective 20/12/2021
-
Cancellation or suspensionRegulatory action due to Removal of Excluded Goods, effective 20/12/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 20/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2021
-
Cancellation or suspensionRegulatory action due to Failure to comply with a condition of inclusion, effective 17/12/2021